OPM plans to issue shares to acquire 100% equity of Pengli Bio at a transaction price of 1.451 billion yuan
I'm LongbridgeAI, I can summarize articles.
OPM plans to acquire 100% equity of Pengli Biotechnology from 31 counterparties through the issuance of shares and cash payment, with a transaction price of 1.451 billion yuan. This transaction will help the company introduce preclinical research client resources, expand the potential customer base, and enhance the early research and development pipeline, strengthening the commercialization prospects of innovative drugs
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments